Sex steroids (i.e., reproductive hormones) have biologic and pathophysiologic actions in the lung mediated by both genomic and non-genomic mechanisms. This session will review the biology of sex steroids and their receptors in the lung, discuss the impact of sex steroids on lung structure and function, and explore the role of sex steroid signaling in lung diseases with known gender differences in incidence and in morbidity and mortality. The learner will better understand the impact of sex steroids on disease manifestation and severity and will appreciate the potential for these hormones as biomarkers and therapeutic targets in lung disease.
CME credits and/or Certificates of Completion are not provided for this session.
1- Learn new findings about the effects of sex steroid signaling on lung structure and function
2- Apply knowledge about sex steroids to management of patients with non-neoplastic lung diseases
3- Apply knowledge about sex steroids to management of patients with lung cancer
Y. S. Prakash, MD, PhD: Introduction To Sex Steroid Signaling And Effects On Lung Structure And Function
Margarget R. MacLean, PhD: The Role of Sex Steroid Signaling in Pulmonary Hypertension
Joe G. Zein, MD, PhD, MBA: The Role of Sex Steroid Signaling in Asthma
M. Patricia Rivera, MD, ATSF: The Role of Sex Steroid Signaling in Lung Cancer
Sergio Chiarella, MD: The Role of Sex Steroid Signaling in COVID-19 Infection
You can save 20% today by joining the ATS.Join more than 16,000 healthcare providers and researchers as a member of the American Thoracic Society today. As an ATS member, you’ll gain access to cutting-edge science, collaboration opportunities, discounts on the annual ATS International Conference, and resources to share with patients. The ATS offers multiple ways to get involved, from Assembly membership to in-person networking opportunities, as well as an online community offered through DocMatter. Join the ATS Today!